Form 8-K - Current report:
SEC Accession No. 0001193125-20-296971
Filing Date
2020-11-18
Accepted
2020-11-18 16:18:54
Documents
15
Period of Report
2020-11-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d61630d8k.htm   iXBRL 8-K 28661
2 EX-1.1 d61630dex11.htm EX-1.1 202634
3 EX-5.1 d61630dex51.htm EX-5.1 8476
7 GRAPHIC g61630g92f80.jpg GRAPHIC 9763
  Complete submission text file 0001193125-20-296971.txt   427017

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA kod-20201117.xsd EX-101.SCH 3092
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE kod-20201117_lab.xml EX-101.LAB 18124
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kod-20201117_pre.xml EX-101.PRE 11421
8 EXTRACTED XBRL INSTANCE DOCUMENT d61630d8k_htm.xml XML 3337
Mailing Address 1200 PAGE MILL RD PALO ALTO CA 94304
Business Address 1200 PAGE MILL RD PALO ALTO CA 94304 650-281-0850
Kodiak Sciences Inc. (Filer) CIK: 0001468748 (see all company filings)

EIN.: 270476525 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38682 | Film No.: 201325327
SIC: 2836 Biological Products, (No Diagnostic Substances)